Real-world Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-17 Inhibitors: A 16-week Multicenter Retrospective Review

被引：0
|
作者：
Sood, Siddhartha [1 ]
Rimke, Alexander [2 ]
Rankin, Brian [3 ]
Abduelmula, Abrahim [4 ]
Georgakopoulos, Jorge [4 ]
Maliyar, Khalad [4 ]
Bagit, Ahmed [1 ]
Leung, Fernejoy [5 ]
Devani, Alim [5 ]
Vender, Ronald [6 ]
Yeung, Jensen [4 ]
Prajapati, Vimal [3 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Dermatol Res Inst, Calgary, AB, Canada
[3] Univ Calgary, Div Dermatol, Dept Med, Calgary, AB, Canada
[4] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON, Canada
[5] Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[6] McMaster Univ, Div Dermatol, Dept Med, Hamilton, ON, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0594
引用
收藏
页码：1216 / 1217
页数：2
相关论文
共 50 条
  • [21] Real-life Experience of Bimekizumab in 27 Obese Patients with Plaque-type Psoriasis: A 24-week Multicenter Retrospective Study
    Fratton, Zeno
    Maione, Vincenzo
    Bighetti, Stefano
    Bettolini, Luca
    Stinco, Giuseppe
    Errichetti, Enzo
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2025, 15 (01):
  • [22] Real-World Effectiveness and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Adult Patients: A 52-Week Multicenter Retrospective Study
    Yeung, Jensen
    Sood, Siddhartha
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
  • [23] Real-World Experience of Spesolimab for Generalized Pustular Psoriasis Flares in Adult Patients: A Multicenter Retrospective Study
    Yeung, Jensen
    Sood, Siddhartha
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025, 26 (01) : 151 - 153
  • [24] Real-World Experience Using Bimekizumab in a Patient Cohort With Plaque-Type Psoriasis and Chronic Kidney Disease: A 48-Week Retrospective Multicentre Study
    Fratton, Zeno
    Balato, Anna
    Bighetti, Stefano
    Bettolini, Luca
    Maione, Vincenzo
    Calzavara-Pinton, Piergiacomo
    Buononato, Dario
    Stinco, Giuseppe
    Errichetti, Enzo
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2025,
  • [25] Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis)
    Orsini, D.
    Megna, M.
    Assorgi, C.
    Balato, A.
    Balestri, R.
    Bernardini, N.
    Bettacchi, A.
    Bianchelli, T.
    Bianchi, L.
    Buggiani, G.
    Burlando, M.
    Brunasso, A. M. G.
    Caldarola, G.
    Cameli, N.
    Campanati, A.
    Campione, E.
    Carugno, A.
    Chersi, K.
    Conti, A.
    Costanzo, A.
    Cozzani, E.
    Cuccia, A.
    D'Amico, D.
    Dal Bello, G.
    Dall'Olio, E. G.
    Dapavo, P.
    De Simone, C.
    Di Brizzi, E. V.
    Di Cesare, A.
    Dini, V.
    Esposito, M.
    Errichetti, E.
    Fargnoli, M. C.
    Fiorella, C. S.
    Foti, A.
    Fratton, Z.
    Gaiani, F. M.
    Gisondi, P.
    Giuffrida, R.
    Giunta, A.
    Guarneri, C.
    Legori, A.
    Loconsole, F.
    Malagoli, P.
    Narcisi, A.
    Paolinelli, M.
    Potestio, L.
    Prignano, F.
    Rech, G.
    Rossi, A.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [26] Treatment outcomes of secukinumab in adult patients with moderate-to-severe plaque psoriasis in China: A real-world multicenter retrospective study
    Ding, Yangfeng
    Li, Wei
    Guan, Xin
    Liu, Na
    Zhou, Ying
    Li, Gaojie
    Wang, Xiaohua
    Wang, Zhidong
    Xiao, Xiao
    Yang, Bin
    Lv, Chengzhi
    Zhang, Chunlei
    Shi, Yuling
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1803 - 1814
  • [27] Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study
    Megna, Matteo
    Di Costanzo, Luisa
    Argenziano, Giuseppe
    Balato, Anna
    Colasanti, Paola
    Cusano, Francesco
    Galluccio, Antonia G.
    Gambardella, Alessio
    Lembo, Serena
    Mozzillo, Raffaele
    Di Luzio, Genoveffa Scotto
    Fabbrocini, Gabriella
    Balato, Nicola
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 855 - 861
  • [28] Switching within the class of IL-17 inhibitors for the treatment of plaque psoriasis: A real-world retrospective study
    Koumprentziotis, Ioannis-Alexios
    Rompoti, Natalia
    Stefanaki, Irene
    Vavouli, Charitomeni
    Papoutsaki, Marina
    Politou, Maria
    Stratigos, Alexander
    Nicolaidou, Electra
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024,
  • [29] Real-world experience with ustekinumab for the treatment of plaque psoriasis in pediatric patients: A retrospective, single-center chart review
    Ladha, Malika A.
    Rankin, Brian D.
    Adly, Merna
    Stevenson, Rebeka
    Luca, Nadia J.
    Devani, Alim R.
    Prajapati, Vimal H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (05) : 1143 - 1145
  • [30] Efficacy and safety of ixekizumab, an interleukin-17A monoclonal antibody, in real-world patients with psoriasis: 12-week results from a Canadian multicenter retrospective study
    Georgakopoulos, Jorge R.
    Phung, Michelle
    Ighani, Arvin
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB120 - AB120
12345